ASMB
Price
$35.52
Change
-$0.33 (-0.92%)
Updated
Nov 13 closing price
Capitalization
561.82M
Intraday BUY SELL Signals
PRQR
Price
$2.16
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Capitalization
227.55M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASMB vs PRQR

Header iconASMB vs PRQR Comparison
Open Charts ASMB vs PRQRBanner chart's image
Assembly Biosciences
Price$35.52
Change-$0.33 (-0.92%)
Volume$197.71K
Capitalization561.82M
ProQR Therapeutics
Price$2.16
Change-$0.00 (-0.00%)
Volume$281.17K
Capitalization227.55M
ASMB vs PRQR Comparison Chart in %
ASMB
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASMB vs. PRQR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a Buy and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ASMB: $35.52 vs. PRQR: $2.16)
Brand notoriety: ASMB and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASMB: 141% vs. PRQR: 57%
Market capitalization -- ASMB: $561.82M vs. PRQR: $227.55M
ASMB [@Biotechnology] is valued at $561.82M. PRQR’s [@Biotechnology] market capitalization is $227.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASMB’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ASMB’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, ASMB is a better buy in the long-term than PRQR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASMB’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • ASMB’s TA Score: 4 bullish, 4 bearish.
  • PRQR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ASMB is a better buy in the short-term than PRQR.

Price Growth

ASMB (@Biotechnology) experienced а +13.81% price change this week, while PRQR (@Biotechnology) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASMB($562M) has a higher market cap than PRQR($228M). ASMB YTD gains are higher at: 125.095 vs. PRQR (-18.491). PRQR has higher annual earnings (EBITDA): -35.56M vs. ASMB (-43.39M). PRQR has more cash in the bank: 120M vs. ASMB (75M). ASMB has less debt than PRQR: ASMB (2.88M) vs PRQR (16.9M). ASMB has higher revenues than PRQR: ASMB (33.2M) vs PRQR (16.5M).
ASMBPRQRASMB / PRQR
Capitalization562M228M246%
EBITDA-43.39M-35.56M122%
Gain YTD125.095-18.491-677%
P/E RatioN/AN/A-
Revenue33.2M16.5M201%
Total Cash75M120M63%
Total Debt2.88M16.9M17%
FUNDAMENTALS RATINGS
ASMB vs PRQR: Fundamental Ratings
ASMB
PRQR
OUTLOOK RATING
1..100
2683
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3560
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5010

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASMB's Valuation (29) in the Pharmaceuticals Other industry is in the same range as PRQR (31) in the Biotechnology industry. This means that ASMB’s stock grew similarly to PRQR’s over the last 12 months.

ASMB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ASMB’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's SMR Rating (98) in the Biotechnology industry is in the same range as ASMB (99) in the Pharmaceuticals Other industry. This means that PRQR’s stock grew similarly to ASMB’s over the last 12 months.

ASMB's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as PRQR (60) in the Biotechnology industry. This means that ASMB’s stock grew similarly to PRQR’s over the last 12 months.

ASMB's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ASMB’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASMBPRQR
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 22 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ASMB
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIRZF10.13N/A
N/A
Sir Rty Income Fund
KSFTF4.43N/A
N/A
Kingsoft Corporation Limited
OKIEY12.10N/A
N/A
OKI Electric Industry Co., Ltd.
SSUMF30.94N/A
N/A
Sumitomo Corp.
TGNT0.04N/A
-4.04%
Totaligent Inc.

ASMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with SPRC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
-0.92%
SPRC - ASMB
45%
Loosely correlated
-7.91%
RGNX - ASMB
34%
Loosely correlated
+0.34%
KYTX - ASMB
34%
Loosely correlated
-11.60%
PRQR - ASMB
34%
Loosely correlated
N/A
ORMP - ASMB
33%
Loosely correlated
-2.83%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
N/A
RGNX - PRQR
46%
Loosely correlated
+0.43%
BEAM - PRQR
45%
Loosely correlated
-2.71%
ETHZ - PRQR
44%
Loosely correlated
+0.89%
SYRE - PRQR
43%
Loosely correlated
+0.34%
ENVB - PRQR
43%
Loosely correlated
+0.67%
More